Oral Sustained Release of a Hydrophilic Drug Using the Lauryl Sulfate Salt/Complex.

@article{Kasashima2016OralSR,
  title={Oral Sustained Release of a Hydrophilic Drug Using the Lauryl Sulfate Salt/Complex.},
  author={Yuuki Kasashima and K. Yoshihara and T. Yasuji and K. Sako and S. Uchida and N. Namiki},
  journal={Chemical & pharmaceutical bulletin},
  year={2016},
  volume={64 9},
  pages={
          1304-9
        }
}
The objective of this study was to establish the key factor of the lauryl sulfate (LS) salt/complex for sustained release of a hydrophilic drug at various physiological pH levels. Mirabegron is a hydrophilic drug that exhibits pH-dependent solubility. Sodium lauryl sulfate (SLS) bound to mirabegron in a stoichiometric manner. The formation of the LS salt/complex significantly reduced mirabegron solubility and helped achieve sustained release of mirabegron over a wide range of pH levels. In… Expand
3 Citations
Oral sustained-release suspension based on a lauryl sulfate salt/complex.
  • 7
A novel in vivo predictive dissolution testing coupled with a modeling and simulation for hydrogel matrix monolithic extended release oral dosage forms.
  • A. Kambayashi, J. Dressman
  • Materials Science, Medicine
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2019
  • 3

References

SHOWING 1-10 OF 27 REFERENCES
Bioavailability of cyclosporin A dispersed in sodium lauryl sulfate-dextrin based solid microspheres.
  • 61
Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix.
  • S. Jeong, K. Park
  • Chemistry, Medicine
  • International journal of pharmaceutics
  • 2008
  • 49
Development of cyclosporin A-loaded hyaluronic microsphere with enhanced oral bioavailability.
  • 27
Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices.
  • M. Varma, A. Kaushal, S. Garg
  • Chemistry, Medicine
  • Journal of controlled release : official journal of the Controlled Release Society
  • 2005
  • 100
Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants.
  • 57
...
1
2
3
...